Business Description
Medacta Group SA
ISIN : CH0468525222
Share Class Description:
XSWX:MOVE: Ordinary SharesCompare
Compare
Traded in other countries / regions
MOVE.SwitzerlandMOVEz.UK6MD.GermanyMEDGF.USA IPO Date
2019-04-04Description
Medacta Group SA is a Switzerland based company involved in developing, manufacturing and distributing orthopedic and neurosurgical medical devices. The company offers solutions for Hip, Knee, Shoulder and Spine. The majority of the company's revenue is generated from Europe, Middle East, and Africa (EMEA) and the rest from other regions.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.1 | |||||
| Equity-to-Asset | 0.47 | |||||
| Debt-to-Equity | 0.61 | |||||
| Debt-to-EBITDA | 1.61 | |||||
| Interest Coverage | 10.61 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 5.79 | |||||
| Beneish M-Score | -2.58 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 13.8 | |||||
| 3-Year EBITDA Growth Rate | 10.4 | |||||
| 3-Year EPS without NRI Growth Rate | 3.8 | |||||
| 3-Year Book Growth Rate | 20.6 | |||||
| Future 3-5Y Total Revenue Growth Rate | 14.64 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 41.88 | |||||
| 9-Day RSI | 36.05 | |||||
| 14-Day RSI | 34.85 | |||||
| 6-1 Month Momentum % | 20.88 | |||||
| 12-1 Month Momentum % | 6.93 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.33 | |||||
| Quick Ratio | 0.9 | |||||
| Cash Ratio | 0.14 | |||||
| Days Inventory | 421.98 | |||||
| Days Sales Outstanding | 62.9 | |||||
| Days Payable | 81.36 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.24 | |||||
| Dividend Payout Ratio | 0.12 | |||||
| Forward Dividend Yield % | 0.5 | |||||
| 5-Year Yield-on-Cost % | 0.25 | |||||
| 3-Year Average Share Buyback Ratio | 0.1 | |||||
| Shareholder Yield % | -0.39 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 68.12 | |||||
| Operating Margin % | 14.61 | |||||
| Net Margin % | 9.31 | |||||
| FCF Margin % | -1.4 | |||||
| ROE % | 15.68 | |||||
| ROA % | 7.35 | |||||
| ROIC % | 10.44 | |||||
| ROC (Joel Greenblatt) % | 14.98 | |||||
| ROCE % | 12.57 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 48.04 | |||||
| PE Ratio without NRI | 48.04 | |||||
| Price-to-Owner-Earnings | 73.49 | |||||
| PEG Ratio | 5.11 | |||||
| PS Ratio | 4.48 | |||||
| PB Ratio | 7.02 | |||||
| Price-to-Tangible-Book | 8.39 | |||||
| Price-to-Operating-Cash-Flow | 30.42 | |||||
| EV-to-EBIT | 37.61 | |||||
| EV-to-Forward-EBIT | 26.44 | |||||
| EV-to-EBITDA | 20.09 | |||||
| EV-to-Forward-EBITDA | 16.51 | |||||
| EV-to-Revenue | 4.87 | |||||
| EV-to-Forward-Revenue | 4.52 | |||||
| EV-to-FCF | -347.03 | |||||
| Price-to-Projected-FCF | 7.12 | |||||
| Price-to-Peter-Lynch-Fair-Value | 5.41 | |||||
| Price-to-Graham-Number | 4.25 | |||||
| Earnings Yield (Greenblatt) % | 2.66 | |||||
| FCF Yield % | -0.31 | |||||
| Forward Rate of Return (Yacktman) % | 9.56 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medacta Group SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil CHF) | 489.979 | ||
| EPS (TTM) (CHF) | 2.282 | ||
| Beta | 1.35 | ||
| Volatility % | 31.31 | ||
| 14-Day RSI | 34.85 | ||
| 14-Day ATR (CHF) | 3.11235 | ||
| 20-Day SMA (CHF) | 115.35 | ||
| 12-1 Month Momentum % | 6.93 | ||
| 52-Week Range (CHF) | 98.1 - 135 | ||
| Shares Outstanding (Mil) | 19.93 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medacta Group SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medacta Group SA Stock Events
| Event | Date | Price(CHF) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medacta Group SA Frequently Asked Questions
What is Medacta Group SA(XSWX:MOVE)'s stock price today?
The current price of XSWX:MOVE is CHF110.60. The 52 week high of XSWX:MOVE is CHF135.00 and 52 week low is CHF98.10.
When is next earnings date of Medacta Group SA(XSWX:MOVE)?
The next earnings date of Medacta Group SA(XSWX:MOVE) is 2024-09-20 Est..
Does Medacta Group SA(XSWX:MOVE) pay dividends? If so, how much?
The Dividend Yield %  of Medacta Group SA(XSWX:MOVE) is 0.24% (As of Today), Highest Dividend Payout Ratio of Medacta Group SA(XSWX:MOVE) was 0.22. The lowest was 0.12. And the median was 0.17. The  Forward Dividend Yield % of Medacta Group SA(XSWX:MOVE) is 0.5%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers